Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

November 1, 2012
The dressing has been applied to one side (M). The difference in skin reaction is apparent.

(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University of Otago, Wellington and a team of radiation therapists in public hospitals in Dunedin, Wellington and Palmerston North and Auckland Radiation Oncology.

The findings of the study, recently published in the international journal Cancer Science and Therapy, show that silicone based dressings decrease painful caused by better than conventional aqueous cream.

The investigated the effect of silicone based Mepilex Lite dressings on the severity of painful skin reactions experienced by 80 women treated with radiation therapy for . The affected skin was divided into two equal halves; one half was randomized to be treated with dressings and the other with aqueous control cream.

The dressings decreased both the visible signs of the skin reactions as well as the severity of the symptoms. Most patients preferred the dressings over the cream and found them easy to use and comfortable to wear.

"These results will be of great benefit to people undergoing radiation therapy for breast and head and neck cancers as radiation can cause severe skin reactions by damaging the cells responsible for skin renewal and this really impacts on their quality of life," says lead researcher Dr Patries Herst.

The severity of the reactions varies from redness to flaking to weeping and ulceration. Severe skin reactions are extremely painful particularly in places where clothing rubs and presses on the damaged skin. There is currently no standard treatment for these skin reactions.

The dressings do not contain any chemicals but stop friction between the fragile skin and clothing, giving the radiation damaged skin time to heal. A very thin layer of silicon allows the dressings to stick closely to healthy skin but not to weeping skin, making them easy and painless to remove.

Dr Herst is continuing her investigations into the use of these dressings and hopes that they will become part of standard care in radiation therapy departments in New Zealand in the near future.

Breast cancer is the most common malignancy in New Zealand women; around 2800 women are diagnosed every year, with a significant number receiving radiation therapy as part of their treatment.

Explore further: Vitamin C may enhance radiation therapy for aggressive brain tumors

Related Stories

IMRT reduces risk of side effects in breast cancer patients

March 28, 2012

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.